Skip to main content
. 2019 Jan 29;63(2):e01040-18. doi: 10.1128/AAC.01040-18

FIG 4.

FIG 4

Efficacy of human-simulated exposures of cefiderocol and cefepime compared with same-period untreated controls at 24, 48, and 72 h among Enterobacteriaceae. Isolate cefiderocol preexposure MICs (μg/ml): E. coli 458, 1/512 (A); K. pneumoniae 539, 4/>512 (B); K. pneumoniae 543, 8/>512 (C). Absence of control data at any given interval indicates zero survival for that isolate.